ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
30 announcements with these filters
TruAlt Bioenergy filed Crisil's monitoring agency report for the quarter ended 30 September 2026 on its Rs 750 crore IPO proceeds. The report notes no deviation from the IPO objects.
TruAlt reported massive 606% YoY revenue growth, turning profitable despite raw material price surges. Management is pivoting from ethanol to high-margin CBG to insulate from feedstock volatility.
Q2 FY27 consolidated total income ₹823.74 Cr, PAT ₹34.99 Cr, EBITDA margin 12.47%. H1 PAT ₹94.27 Cr, EBITDA ₹233.92 Cr (16.27% margin). Strategy: integrated bioenergy across ethanol, CBG, SAF, retail.
TruAlt Bioenergy reported H1 FY27 revenue of ₹1,437.98 crore, EBITDA of ₹233.92 crore and PAT of ₹94.27 crore via press release. Results reverse last year's H1 loss.
TruAlt Bioenergy Ltd reported revenue from operations of ₹811.1 Cr (+605.9% YoY) and net profit of ₹35 Cr for Q2 FY27.
Mr. Monu Kumar resigned as Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, effective October 16, 2026, due to personal reasons.
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.
TruAlt Bioenergy announced a board meeting on October 23, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
TruAlt Bioenergy issued a postal ballot notice to appoint Dr. Patil as Non-Executive Independent Director for one year. E-voting runs October 14 to November 12, 2026.
Promoter Group entity Nirani Holdings Private Limited acquired 196,129 equity shares of Trualt Bioenergy Ltd via market purchase, increasing their stake by 0.17%.
Nirani Holdings Private Limited (Promoter Group) acquired 1,96,129 equity shares of TruAlt Bioenergy Limited from the open market for ₹9.09 Crore.
Trualt Bioenergy promoter Kamala Murugesh Nirani (Promoter Group) created a pledge on 300,000 equity shares, valued at ₹13.17 Crore.
Promoter group entity Nirani Holdings Private Limited acquired 1.22 lakh shares of TruAlt Bioenergy Limited from the open market for Rs. 5.57 Crore.
Promoter entity Nirani Holdings Private Limited acquired 1,52,201 shares of TruAlt Bioenergy Limited worth Rs. 6.69 Crore via open market, increasing stake to 2.11%.
Nirani Holdings, part of Trualt Bioenergy's promoter group, pledged 14 lakh equity shares valued at ₹58.10 Crore.
TruAlt Bioenergy Limited reported the creation of a pledge on 14,00,000 equity shares held by promoter entity Nirani Holdings Private Limited.
TruAlt Bioenergy's Board commented on a ₹0.05 Cr exchange fine for Listing Regulation non-compliance. The company appointed a Woman Independent Director and paid the penalty.
Trualt Bioenergy Limited will acquire an additional stake in its subsidiary, Leafiniti Bioenergy Private Limited, for ₹21.42 Crore to maintain its proportionate shareholding.
TruAlt Bioenergy will invest Rs. 8.27 Crore to acquire additional equity shares in its subsidiary, TruAlt Sumi Gas Private Limited, to support growth objectives.
Trualt Bioenergy Limited has appointed Dr. Sarvamangala R. Patil as a Non-Executive Independent Director. This board-level appointment adds expertise in biotechnology, sustainability, and industrial development.
TruAlt Bioenergy approved investments totaling ₹29.69 Crore in two subsidiaries, Leafiniti Bioenergy and TruAlt Sumi Gas, to support their expansion plans.
Nirani Holdings, a promoter group entity, acquired 50,000 shares of TruAlt Bioenergy for Rs. 2.12 Crore from the open market.
Promoter group entity Nirani Holdings acquired 69,575 shares of TruAlt Bioenergy for Rs. 2.94 Crore. This increases the promoter group's total shareholding by 0.08%.
Promoter group entity Nirani Holdings Private Limited acquired 98,700 equity shares of TruAlt Bioenergy Limited worth ₹4.06 Crore from the open market.
TruAlt Bioenergy held its 5th Annual General Meeting on August 31, 2026. The meeting covered adoption of financial statements and routine business appointments.
TruAlt Bioenergy faces a fine from NSE and BSE for non-compliance with board composition norms (Regulation 17(1)). The company is reviewing the notices received.
TruAlt Bioenergy received notices from NSE and BSE regarding fines for board composition non-compliance. The total penalty imposed is Rs. 9.10 Lakhs.
TruAlt Bioenergy Limited received a GST demand order of ₹6.60 Crore including tax, interest, and penalties from the Karnataka tax authorities regarding excess Input Tax Credit claims.
TruAlt Bioenergy Limited promoter group entity, Nirani Holdings Private Limited, acquired 20,000 equity shares. This open-market purchase increases the promoter group stake to 1.68%.
Promoter Nirani Holdings Private Limited acquired 24,200 equity shares of TruAlt Bioenergy Limited. This transaction increased their stake from 1.63% to 1.65%.